FDA Okays Drug to Curb Pancreatitis in Hypertriglyceridemia

The expanded indication makes olezarsen the first therapy approved to reduce the acute pancreatitis risk in adults with severe hypertriglyceridemia.
Medscape Medical News

Source link : https://www.medscape.com/viewarticle/fda-okays-drug-curb-acute-pancreatitis-severe-2026a1000lhk?src=rss

Author :

Publish date : 2026-06-24 19:41:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

FDA Okays Drug to Curb Pancreatitis in Hypertriglyceridemia

Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk

Related Posts

Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk

Why women are more affected by hot weather than men

Screwworm could be the first species targeted by an ‘extinction drive’

Nature Retracts Cancer Study Linking Treatment Timing to Survival

How a Drug With More Negative Than Positive Studies Won FDA Approval

LSD’s Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

FDA Okays Drug to Curb Pancreatitis in Hypertriglyceridemia

Severe Hypertriglyceridemia Drug Approved to Reduce Triglycerides, Pancreatitis Risk

Why women are more affected by hot weather than men

Screwworm could be the first species targeted by an ‘extinction drive’

Nature Retracts Cancer Study Linking Treatment Timing to Survival

How a Drug With More Negative Than Positive Studies Won FDA Approval

LSD’s Depression Win; Summer Heat and Suicide; Antipsychotic Nonresponse Predictors

Could TILs Serve as a Marker of Immunotherapy Benefit in Early TNBC?

Categories

Archives